Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis
- 1 November 2003
- journal article
- Published by Wolters Kluwer Health in PAIN®
- Vol. 106 (1) , 35-42
- https://doi.org/10.1016/s0304-3959(03)00274-4
Abstract
The objective of this study was to adapt the concept of 'episode-free day', a metric for measuring symptom relief in daily units, to the clinical outcome literature for persistent pain. The episode-free day metric is widely used in other medical literature, but no analogous measure exists in pain literature. Prior focus groups with this population suggested that a 'Day of Manageable Pain Control' was an appropriate name for the metric. In the present study, in order to derive a statistical criterion for 'Manageable Day', we used Serlin et al.'s (Pain 61 (1995) 277) cut-point derivation method to derive a single cut-point on a 0-10 scale of average pain that divided groups with significant persistent pain optimally on pain-related functional interference. Participants were 194 patients with moderate-severe low back pain (n=96) or osteoarthritis (n=98). For both patient samples, '5' was the cut-point that optimally distinguished groups on pain-related interference. '5-8' and '5-7' were double cut-point solutions that optimally divided LBP and OA samples into three categories (e.g. lowest, medium and highest average pain), respectively. Derived cut-points were confirmed using a variety of measures of functional disability. Together with research that showed that average pain ratings of approximately 5 and below permit increased function and quality of life in patients with moderate to severe low back pain and osteoarthritis, our findings provide support for the use of 0-5 on a 0-10 numeric average pain severity scale as one possible criterion for a Manageable Day.Keywords
This publication has 12 references indexed in Scilit:
- Cost-Effectiveness of a Program to Prevent Depression Relapse in Primary CareMedical Care, 2002
- Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxenOsteoarthritis and Cartilage, 2002
- The Cost Effectiveness of Early Treatment with Fluticasone Propionate 250 μ g Twice a Day in Subjects with Obstructive Airway DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Pain site and the effects of amputation pain: further clarification of the meaning of mild, moderate, and severe painPublished by Wolters Kluwer Health ,2001
- When is cancer pain mild, moderate or severe? Grading pain severity by its interference with functionPain, 1995
- The Episode-Free Day as a Composite Measure of EffectivenessPharmacoEconomics, 1993
- Cost-effectiveness analysis.BMJ, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- The impact of pain on the patient with cancerCancer, 1984
- A Study of the Natural History of Back PainSpine, 1983